Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |